Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3347340 42 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Despite that COPD remains one of the most common respiratory diseases worldwide, it can be managed effectively with certain treatments and, more importantly, be prevented by the early implementation of various measures. The pathology and pathophysiology of this disease continue to be studied, with new pharmacological and invasive therapies emerging. In this consensus paper, the Working Group of the Hellenic Thoracic Society aimed to consolidate the up-to-date information and new advances in the treatment of COPD. Local and international data on its prevalence are presented, with revised strategies on the diagnostic approach and the evaluation of risk assessment and disease severity classification. Emphasis is placed on the management and therapy of patients with COPD, covering both common principles, specialized modalities, and algorithms to distinguish between home care and the need for hospitalization. Although pharmacological treatment is commonly recognized in COPD, an integrative approach of pulmonary rehabilitation, physical activity, patient education, and self-assessment should be encountered for a comprehensive treatment, prevention of exacerbations, and increased quality of life in patients. © 2022 by the authors.
Έτος δημοσίευσης:
2022
Συγγραφείς:
Tzanakis, N.
Kosmas, E.
Papaioannou, A.I.
Hillas, G.
Zervas, E.
Loukides, S.
Bakakos, P.
Katsaounou, P.
Boutou, A.
Perlikos, P.
Rovina, N.
Dimakou, K.
Steiropoulos, P.
Stratakos, G.
Emmanouil, P.
Tryfon, S.
Koulouris, N.
Περιοδικό:
International Journal of Person-Centered Medicine
Εκδότης:
MDPI
Τόμος:
12
Αριθμός / τεύχος:
12
Λέξεις-κλειδιά:
aclidinium bromide; azithromycin; bronchodilating agent; corticosteroid; formoterol; glycopyrronium; indacaterol; olodaterol; Pneumococcus vaccine; salmeterol; tiotropium bromide; umeclidinium; vasoconstrictor agent; vilanterol, abnormal respiratory sound; acute respiratory failure; airway obstruction; algorithm; antibiotic resistance; anxiety; arterial gas; Article; artificial ventilation; asthma; atelectasis; blood gas analysis; breathing rate; bronchiectasis; bronchodilatation; chronic bronchitis; chronic kidney failure; chronic obstructive lung disease; computer assisted tomography; coughing; dyspnea; echocardiography; environmental exposure; fatigue; forced expiratory volume; forced vital capacity; genetic risk; Greek (people); Haemophilus influenzae; health care personnel; health care system; holistic care; hospitalization; human; hypercapnia; hypoxemia; immune response; immunization; immunogenicity; immunosuppressive treatment; influenza; kyphoscoliosis; lifestyle modification; lung artery pressure; lung cancer; lung function; lung ventilation; obesity; occupational exposure; oxygen saturation; oxygen therapy; passive smoking; pathophysiology; physical activity; pneumothorax; prick test; Pseudomonas aeruginosa; pulmonary hypertension; pulmonary rehabilitation; quality of life; respiratory function; respiratory tract infection; risk assessment; risk factor; sleep disordered breathing; spirometry; sputum culture; Streptococcus pneumoniae; thorax radiography; tracheostomy
Επίσημο URL (Εκδότης):
DOI:
10.3390/jpm12121997
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.